Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study

British Journal of Dermatology

Volumn 137, Issue 4, 1997, Pages 549-557

  Miracco, C ^a   Rubegni, P ^a   De Aloe, G ^a   D'Ascenzo, G ^a   Mazzatenta, C ^a   De Santi, M M ^a   Fimiani, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME;

AGED; APOPTOSIS; CELL DIVISION; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PHOTOPHERESIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0030731588     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03785.x     Document Type: Article

References (45)

1. Edelson RL. Photopheresis. J Clin Apheresis 1990; 5: 77-9.
2. Heald P, Rook A, Perez M et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992; 27: 427-33.
3. Holloway BH, Floweres PF, Ramos-Caro KA. Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992; 27: 367-78.
4. Zic J, Arzubiaga C, Salhani KE et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Denmitol 1992; 27: 729-36.
5. Fimiani M, Rubegni P, D'Ascenzo G, Andreassi L. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1994; 31: 828-9.
6. Zachariae H, Bjerring P, Brodthagen U, Sogaard H. Photopheresis in the red man or pre-Sézary syndrome. Dermatology 1995; 190: 132-5.
7. Bakels V, van Oostveen JW, Gordijn RLJ et al. Frequency and prognostic significance of clonal T-cell receptor β-gene rearrangements in the peripheral blood of patients with mycosis fungoides. Arch Dermatol 1992; 92: 1602-7.
8. Bunn PA, Hoffman SJ, Norris D et al. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 1994; 121: 592-602.
9. Perez M, Edelson RL, Laroche L, Berger C. Specific suppression of antiallograft immunity by immunization with syngenic photoinactivated effector lymphocytes. J Invest Dermatol 1989; 92: 669-76.
10. Ben-Nun A, Wekerle H, Cohen IR. Vaccination against autoimmune encephalomyelitis with T lymphocytes line cells reactive against myelin basic protein. Nature 1981; 292: 60-1.
11. Lider O, Reshef T, Beraud E et al. Antidiotypic network induced by T-cell vaccination against experimental autoimmune encephalomyelitis. Science 1988; 239: 181-3.
12. Vowels BR, Cassin M, Boulai MH et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: implication for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992; 122: 686-92.
13. Scheuric P, Thoma B, Ucer U, Pfizenmaier K. Immunoregulatory activity of recombinant human Tumor Necrosis Factor (TNF) -alfa: induction of TNF receptors on human T-cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 1987; 138: 1786-90.
14. Beutler B, Cerami A. The biology of cachectin TNF, a primary mediator of the host response. Annu Rev Immunol 1988; 7: 652-5.
15. Laster SM, Wood JG, Hooding LR. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 1988; 141: 2629-34.
16. Fehsel K, Kolb-Bachofen V, Kolb H. Analysis of TNF-α induced strand breaks at the single cell level. Am J Pathol 1991; 139: 251-4.
17. Fulton AM, Chong YC. The role of macrophages-derived TNFα in the induction of sublethal tumor cell UNA damage. Carcinogenesis 1992; 13: 77-81.
18. Cohen JJ. Apoptosis. Immunol Today 1993; 14: 26-30.
19. Grau GE, Lambert PH, Vassalli P, Piguet PF. Tumor necrosis factor/ cachectin as an effector of T cell-dependent immunopathology. Int Rev Pathol 1993; 34b: 159-71.
20. Lemon SV, Martin S, Cotter TG. Induction of apoptosis (programmed cell death) in tumor cell lines by widely diverging stimuli. Biochem Soc Trans 1990; 18: 343-5.
21. Arenas MJ, Willie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 12: 223-54.
22. Hagari Y, Budgeon LR, Pickel MD, Kraider JW. Association of tumor necrosis factor-α gene expression and apoptotic cell death regression of Shope papillomas. J Invest Dermatol 1995; 104: 526-9.
23. EORTC/BMFT, Cutaneous Lymphoma Project Group. Classification and Staging of Cutaneous Lymphoma. A European Concept, 1987.
24. McCarthy KP, Sloane JP, Kabarowki JS et al. The rapid detection of clonal T-cell proliferations in patients with lymphold disorders. Am J Surg Pathol 1991; 138: 821-8.
25. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: PCR Protocols: A Guide to Methods and Applications. New York: Academic Press, 1990: 153-8.
26. Miracco C, Spina D, Santopietro R et al. Apoptotic index: discriminant feature for the differentiation of cutaneous diffuse malignant follicular center cell lymphomas from lymphoid hyperplasia. J Invest Dermatol 1993; 100: 699-704.
27. Gerdes J, Lemke H, Baisch H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-15.
28. Ansari B, Coates PJ, Greenstein BU, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8.
29. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
30. Willie AH, Kerr JFK, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-3.
31. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991; 24: 203-14.
32. Willie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992; 11: 95-103.
33. Akagi Y, Ito K, Sawada S. Radiation-induced apoptosis and necrosis in Molt-4 cells: a study of dose-effect relationships and their modifications. Int J Radiat Biol 1993; 1: 47-56.
34. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-4.
35. Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 1995; 103: 300-7.
36. Searle J, Lawson TA, Abbot PJ et al. An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol 1975; 116: 129.
37. Trauth BC, Klas C, Peters AMJ et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-5.
38. Debatin KM, Goldmann CK, Bamford R et al. Monoclonal antibody-mediated apoptosis in adult T-cell leukemia. Lancet 1990; 335: 497-500.
39. You EK, Rook AH, Elenitsas R et al. Apoptosis induction by ultraviolet light A and photochemotherapy In cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-42.
40. Kerr JFR, Searle J, Harmon BV, Bishop CJ, Apoptosis. In: Perspectives on Mammalian Cell Death (Potten CS, ed.). Oxford: Oxford University Press, 1987; 93-128.
41. Anikulmar TV, Sarraf CE, Hunt T, Alison MR. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer 1992; 65: 552-8.
42. Luger A, Kovarik J, Stummvoll HK et al. Blood-membrane interaction in hemodialysis leads to increased cytokin production. Kidney Int 1987; 32: 84-8.
43. Veelken H, Tycko B, Sklar J. Sensitive detection of clonal antigen receptor gene rearrangements for the diagnosis and monitoring of lymphoid neoplasms by a polymerase chain reaction-mediated ribonuclease protection assay. Blood 1991; 78: 1318-26.
44. Heald P, Knobler R, LaRoche L. Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma. Dermatologic Clinics 1994; 12: 443-9.
45. Malorni W, Rainaldi G, Tritarelli E et al. Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemic cells expressing the p-170 glycoprotein. Int J Cancer 1996; 67: 238-47.